Treatment Advances in Blastic Plasmacytoid Dendritic Cell Neoplasm

H&O What is blastic plasmacytoid dendritic cell neoplasm (BPDCN)? NP BPDCN is an aggressive cancer of the blood and bone marrow that presents clinically as […]

Hem/Onc News

Tagraxofusp-erzs Approved in Blastic Plasmacytoid Dendritic Cell Neoplasm The US Food and Drug Administration (FDA) approved tagraxofusp-erzs (Elzonris, Stemline) on December 21 for blastic plasmacytoid dendritic […]